A double-blind randomized placebo-controlled trial of sibutramine

Obesity Research

Volumn 4, Issue 3, 1996, Pages 263-270

  Bray, George A ^a,b   Ryan, Donna H ^a,b   Gordon, Douglas ^a,b   Heidingsfelder, Sylvia ^a,b   Cerise, Frederick ^a,b   Wilson, Krause ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Appetite suppressants; Norepinephrine; Obesity; Serotonin

Indexed keywords

ANTIDEPRESSANT AGENT; CYCLOBUTANE DERIVATIVE; NORADRENALIN; PHENETHYLAMINE DERIVATIVE; SEROTONIN; SIBUTRAMINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; LIFESTYLE; LOW CALORY DIET; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; BODY MASS INDEX; BODY WEIGHT; COMBINED MODALITY THERAPY; CYCLOBUTANES; DIET, REDUCING; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; NOREPINEPHRINE; OBESITY; PHENETHYLAMINES; SEROTONIN;

EID: 0030147221     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1550-8528.1996.tb00544.x     Document Type: Article

References (6)

1. Astrup A, Buemann B, Christensen NJ, et al. The effect of ephedrine/caffeine mixture on energy expenditure and body composition in obese women. Metabolism. 1992;41(7):686-688.
2. Astrup A, Toubro S, Cannon S, Hein P, Madsen J. Thermogenic synergism between ephedrine and caffeine in healthy volunteers: A double-blind, placebo-controlled study. Metabolism. 1991;40(3):323-329.
3. Bray GA. The Obese Patient. 9th ed. Philadelphia: W.B. Saunders Co.; 1976.
4. Bray GA. Obesity: Basic aspects and clinical applications. Med Clin North Am. 1989;73:1-269.
5. Bray GA. Barriers to the treatment of obesity. Ann Intern Med. 1991;115:152-153.
6. Bray GA. Use and abuse of appetite-suppressant drugs int he treatment of obesity. Ann Intern Med. 1993;119:707-713.